Mitsubishi UFJ Kokusai Asset Management Co. Ltd. reduced its stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 10.5% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 33,135 shares of the medical instruments supplier’s stock after selling 3,867 shares during the period. Mitsubishi UFJ Kokusai Asset Management Co. Ltd.’s holdings in DENTSPLY SIRONA were worth $2,148,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also bought and sold shares of the company. BlackRock Inc. raised its position in DENTSPLY SIRONA by 3,103.7% in the first quarter. BlackRock Inc. now owns 13,891,329 shares of the medical instruments supplier’s stock valued at $867,376,000 after buying an additional 13,457,730 shares during the last quarter. Principal Financial Group Inc. raised its position in DENTSPLY SIRONA by 1,445.2% in the first quarter. Principal Financial Group Inc. now owns 5,292,885 shares of the medical instruments supplier’s stock valued at $330,488,000 after buying an additional 4,950,337 shares during the last quarter. Clearbridge Investments LLC raised its position in DENTSPLY SIRONA by 34.6% in the first quarter. Clearbridge Investments LLC now owns 5,258,060 shares of the medical instruments supplier’s stock valued at $328,313,000 after buying an additional 1,353,040 shares during the last quarter. Point72 Asset Management L.P. acquired a new position in DENTSPLY SIRONA during the first quarter valued at approximately $64,184,000. Finally, Renaissance Technologies LLC raised its position in DENTSPLY SIRONA by 246.0% in the first quarter. Renaissance Technologies LLC now owns 1,044,558 shares of the medical instruments supplier’s stock valued at $65,222,000 after buying an additional 742,700 shares during the last quarter. Hedge funds and other institutional investors own 95.13% of the company’s stock.

Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) opened at 53.76 on Wednesday. DENTSPLY SIRONA Inc. has a 1-year low of $53.21 and a 1-year high of $65.68. The stock’s 50 day moving average is $62.34 and its 200-day moving average is $62.34. The stock’s market cap is $12.34 billion.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its earnings results on Wednesday, August 9th. The medical instruments supplier reported $0.65 earnings per share for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.65. DENTSPLY SIRONA had a positive return on equity of 7.24% and a negative net margin of 20.57%. The firm had revenue of $992.70 million during the quarter, compared to analyst estimates of $1 billion. During the same period in the previous year, the company earned $0.76 EPS. The company’s revenue for the quarter was down 2.9% on a year-over-year basis. On average, analysts anticipate that DENTSPLY SIRONA Inc. will post $2.72 EPS for the current year.

The business also recently announced a quarterly dividend, which will be paid on Friday, October 13th. Investors of record on Friday, September 29th will be issued a $0.0875 dividend. The ex-dividend date is Thursday, September 28th. This represents a $0.35 annualized dividend and a yield of 0.65%. DENTSPLY SIRONA’s dividend payout ratio (DPR) is currently -10.09%.

TRADEMARK VIOLATION WARNING: “Mitsubishi UFJ Kokusai Asset Management Co. Ltd. Lowers Position in DENTSPLY SIRONA Inc. (XRAY)” was first published by Watch List News and is the property of of Watch List News. If you are accessing this article on another domain, it was illegally copied and republished in violation of United States & international copyright and trademark legislation. The correct version of this article can be read at https://www.watchlistnews.com/mitsubishi-ufj-kokusai-asset-management-co-ltd-lowers-position-in-dentsply-sirona-inc-xray/1493690.html.

XRAY has been the topic of several research reports. Goldman Sachs Group, Inc. (The) lowered shares of DENTSPLY SIRONA from a “neutral” rating to a “sell” rating and cut their price target for the company from $60.00 to $55.00 in a report on Tuesday, May 23rd. Zacks Investment Research upgraded shares of DENTSPLY SIRONA from a “sell” rating to a “hold” rating in a report on Wednesday, April 19th. Cleveland Research upgraded shares of DENTSPLY SIRONA from a “neutral” rating to a “buy” rating in a report on Tuesday, May 23rd. HC Wainwright initiated coverage on shares of DENTSPLY SIRONA in a report on Tuesday, July 11th. They issued a “buy” rating and a $74.00 price target on the stock. Finally, BidaskClub lowered shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a report on Wednesday, July 19th. Three investment analysts have rated the stock with a sell rating, three have given a hold rating and eight have assigned a buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus price target of $66.25.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAY).

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.